Technical Analysis for CYBN - Cybin Inc.

Grade Last Price % Change Price Change
C 10.95 -1.87% -0.21
CYBN closed up 1.45 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Boomer Buy Setup Bullish Swing Setup -1.87%
Calm After Storm Range Contraction -1.87%
NR7 Range Contraction -1.87%
Narrow Range Bar Range Contraction -1.87%
Inside Day Range Contraction -1.87%
Gapped Up Strength -1.87%
200 DMA Resistance Bearish -0.45%
Crossed Above 20 DMA Bullish -0.45%
Calm After Storm Range Contraction -0.45%
Inside Day Range Contraction -0.45%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 1 hour ago
2x Volume Pace about 1 hour ago
1.5x Volume Pace about 1 hour ago
Down 3% about 1 hour ago
Fell Below Previous Day's Low about 1 hour ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cybin Inc. Description

Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Drugs Major Depressive Disorder Neurochemistry Psychedelic Drug

Is CYBN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.66
52 Week Low 6.5
Average Volume 347,569
200-Day Moving Average 11.80
50-Day Moving Average 9.92
20-Day Moving Average 10.71
10-Day Moving Average 11.17
Average True Range 1.13
RSI (14) 54.55
ADX 34.18
+DI 21.44
-DI 13.83
Chandelier Exit (Long, 3 ATRs) 10.48
Chandelier Exit (Short, 3 ATRs) 13.02
Upper Bollinger Bands 11.92
Lower Bollinger Band 9.50
Percent B (%b) 0.69
BandWidth 22.65
MACD Line 0.30
MACD Signal Line 0.32
MACD Histogram -0.0132
Fundamentals Value
Market Cap 4.53 Billion
Num Shares 406 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -58.74
Price-to-Sales 278.25
Price-to-Book 3.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.99
Resistance 3 (R3) 12.00 11.74 11.85
Resistance 2 (R2) 11.74 11.53 11.73 11.80
Resistance 1 (R1) 11.45 11.40 11.32 11.44 11.76
Pivot Point 11.19 11.19 11.13 11.18 11.19
Support 1 (S1) 10.90 10.98 10.77 10.89 10.56
Support 2 (S2) 10.64 10.85 10.63 10.52
Support 3 (S3) 10.35 10.64 10.47
Support 4 (S4) 10.34